文献速递毛发、甲与色素性疾病

冷大气等离子体活化水凝胶成功治疗白癜风

Successful Treatment of Vitiligo with Cold Atmospheric Plasma‒Activated Hydrogel.
PubMed 文献 · J Invest Dermatol · 2021-05-21

本研究在小鼠白癜风模型和随机对照试验中评估冷大气等离子体(CAP)的疗效与安全性。CAP局部治疗可恢复小鼠白斑区黑色素分布,减少CD11c+树突状细胞、CD3+和CD8+ T细胞浸润,抑制CXCL10和IFN-γ释放,并通过上调NRF2和降低诱导型一氧化氮合酶活性增强抗氧化能力。在随机对照试验中,CAP治疗使80%的白癜风皮损达到部分复色、20%达到完全复色,治疗及随访期间未出现周围色素沉着或其他不良事件。

要点

  • CAP局部治疗可恢复白癜风小鼠模型皮损的黑色素分布。
  • CAP可减少皮损中CD11c+树突状细胞及CD3+、CD8+ T细胞浸润。
  • 随机对照试验中CAP使80%皮损部分复色、20%完全复色,未报告不良事件。

核心结论

  • CAP是白癜风治疗的一种有前景的选择。

研究设计与样本

  • 研究包括小鼠白癜风模型和针对活动性局灶性白癜风患者的随机对照试验。

主要发现

  • 小鼠模型皮肤活检显示,CAP局部治疗可恢复白斑样病变的黑色素分布。
  • CAP减少CD11c+树突状细胞、CD3+ T细胞和CD8+ T细胞浸润,抑制CXCL10和IFN-γ释放。
  • CAP通过增强NRF2表达和减弱诱导型一氧化氮合酶活性,增强细胞对氧化应激和过度免疫应答的抵抗。
  • 随机对照试验中,CAP治疗使80%的白癜风皮损达到部分复色,20%达到完全复色。
  • 治疗期间及随访期间未出现周围区域色素沉着或其他不良事件。

关键数值与推荐

  • 随机对照试验中CAP治疗的部分复色率为80%,完全复色率为20%。

临床怎么用

  • CAP可作为活动性局灶性白癜风的潜在治疗选择,需进一步临床验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Vitiligo shows insufficient response to current therapies largely owing to T-lymphocyte dysfunction, abnormal inflammatory activation, and excessive oxidative stress in lesions. Cold atmospheric plasma (CAP) possesses pleiotropic antioxidant and anti-inflammatory properties and may offer an improvement to current treatment options. In this study, the efficacy and safety of CAP were investigated in a mouse model of vitiligo and a randomized and controlled trial of patients with active focal vitiligo. Skin biopsies showed that topical treatment of vitiligo-like lesions on mouse dorsal skin by CAP restored the distribution of melanin. In addition, CAP treatment reduced the infiltration of CD11c+ dendritic cells, CD3+ T cells, and CD8+ T cells; inhibited the release of CXCL10 and cytokine IFN-γ; and enhanced cellular resistance to oxidative stress and excessive immune response by enhancing the expression of the transcription factor NRF2 and attenuating the activity of inducible nitric oxide synthase. In a randomized and controlled trial, CAP treatment achieved partial and complete repigmentation in 80% and 20% of vitiligo lesions, respectively, without hyperpigmentation in surrounding areas or other adverse events during the treatment period and its follow-up period. In conclusion, CAP offers a promising option for the management of vitiligo.

来源:J Invest Dermatol,查看原文。版权归原作者所有。

引用

  1. Zhai S, Xu M, Li Q, et al. Successful Treatment of Vitiligo with Cold Atmospheric Plasma‒Activated Hydrogel. J Invest Dermatol. 2021. PMID: 34029575. doi:10.1016/j.jid.2021.04.019

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。